Enhancing the Oral Bioavailability of Biochanin A by Encapsulation in Mixed Micelles Containing Pluronic F127 and Plasdone S630

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2017 Mar 7

PMID 28260893

Citations 10

Authors

Xiaoyan Wu

Weihong Ge

Tengfei Shao

Weijun Wu

Jian Hou

Li Cui

Jing Wang

Zhenghai Zhang

Affiliations

Soon will be listed here.

Abstract

Biochanin A (BCA), a natural dietary isoflavone, has been reported to show anticancer activities. However, its low biological availability and poor aqueous solubility limit its usefulness as a chemotherapeutic agent. We developed BCA-loaded micelles with Pluronic F127 and Plasdone S630 (BCA-FS). The optimized, spherical-shaped BCA-FS was obtained at a ratio of 1:1 (F127:S630). The particle size was 25.17±1.2 nm, and the zeta potential was -10.9±0.24 mV. BCA solubility in water increased to 5.0 mg/mL after encapsulation, and the drug-loading efficiency was 5.88%±0.76%. In vitro release experiments showed a delayed release of BCA from the mixed micelles. Furthermore, the BCA absorption permeability across a Caco-2 cell monolayer from the apical side to the basolateral side increased by 54% in BCA-FS. A pharmacokinetics evaluation showed a 2.16-fold increase in the relative oral bioavailability of BCA-FS compared with raw BCA, indicating that the mixed micelles may promote absorption in the gastrointestinal tract. A gastrointestinal safety assay was used to assess the reliability and safety of BCA-FS. On the basis of these findings, we conclude that this simple nanomicelle system could be leveraged to deliver BCA and other hydrophobic drugs.

Citing Articles

Next-generation cancer nanotherapeutics: Pluronic F127 based mixed micelles for enhanced drug delivery.

Bhalodi K, Kothari C, Butani S Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39527309 DOI: 10.1007/s00210-024-03582-x.

Chemical and Biological Properties of Biochanin A and Its Pharmaceutical Applications.

Feng Z, Lai W Pharmaceutics. 2023; 15(4).

PMID: 37111591 PMC: 10143291. DOI: 10.3390/pharmaceutics15041105.

Engineering the Structure and Rheological Properties of P407 Hydrogels via Reverse Poloxamer Addition.

White J, Garza A, Griebler J, Bates F, Calabrese M Langmuir. 2023; 39(14):5084-5094.

PMID: 36971824 PMC: 10593112. DOI: 10.1021/acs.langmuir.3c00088.

Active Potential of Bacterial Cellulose-Based Wound Dressing: Analysis of Its Potential for Dermal Lesion Treatment.

Hodel K, Machado B, Sacramento G, Maciel C, Oliveira-Junior G, Matos B Pharmaceutics. 2022; 14(6).

PMID: 35745794 PMC: 9228207. DOI: 10.3390/pharmaceutics14061222.

Impact of small molecule and reverse poloxamer addition on the micellization and gelation mechanisms of poloxamer hydrogels.

White J, Calabrese M Colloids Surf A Physicochem Eng Asp. 2022; 638.

PMID: 35221534 PMC: 8880963. DOI: 10.1016/j.colsurfa.2021.128246.

References

Zhang S, Sagawa K, Arnold R, Tseng E, Wang X, Morris M . Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: in vitro and in vivo. J Pharm Sci. 2009; 99(1):430-41. DOI: 10.1002/jps.21827. View

Szliszka E, Czuba Z, Mertas A, Paradysz A, Krol W . The dietary isoflavone biochanin-A sensitizes prostate cancer cells to TRAIL-induced apoptosis. Urol Oncol. 2011; 31(3):331-42. DOI: 10.1016/j.urolonc.2011.01.019. View

Nikander E, Metsa-Heikkila M, Ylikorkala O, Tiitinen A . Effects of phytoestrogens on bone turnover in postmenopausal women with a history of breast cancer. J Clin Endocrinol Metab. 2004; 89(3):1207-12. DOI: 10.1210/jc.2003-031166. View

Jain A, Lai J, Bhushan A . Biochanin A inhibits endothelial cell functions and proangiogenic pathways: implications in glioma therapy. Anticancer Drugs. 2014; 26(3):323-30. DOI: 10.1097/CAD.0000000000000189. View

Li L, Tan Y . Preparation and properties of mixed micelles made of Pluronic polymer and PEG-PE. J Colloid Interface Sci. 2007; 317(1):326-31. DOI: 10.1016/j.jcis.2007.09.053. View

Ling G, Zhang P, Zhang W, Sun J, Meng X, Qin Y . Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition. J Control Release. 2010; 148(2):241-8. DOI: 10.1016/j.jconrel.2010.08.010. View

Lee K, Choi E . Biochanin A stimulates osteoblastic differentiation and inhibits hydrogen peroxide-induced production of inflammatory mediators in MC3T3-E1 cells. Biol Pharm Bull. 2005; 28(10):1948-53. DOI: 10.1248/bpb.28.1948. View

Zhang W, Shi Y, Chen Y, Ye J, Sha X, Fang X . Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials. 2011; 32(11):2894-906. DOI: 10.1016/j.biomaterials.2010.12.039. View

Moon Y, Sagawa K, Frederick K, Zhang S, Morris M . Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats. AAPS J. 2006; 8(3):E433-42. PMC: 2761049. DOI: 10.1208/aapsj080351. View

10.

Bhardwaj V, Tadinada S, Jain A, Sehdev V, Daniels C, Lai J . Biochanin A reduces pancreatic cancer survival and progression. Anticancer Drugs. 2013; 25(3):296-302. DOI: 10.1097/CAD.0000000000000044. View

11.

Dahmani F, Yang H, Zhou J, Yao J, Zhang T, Zhang Q . Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: preparation, in vitro and in vivo evaluation. Eur J Pharm Sci. 2012; 47(1):179-89. DOI: 10.1016/j.ejps.2012.05.015. View

12.

Elgart A, Cherniakov I, Aldouby Y, Domb A, Hoffman A . Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS): the underlying mechanisms for amiodarone and talinolol. Pharm Res. 2013; 30(12):3029-44. DOI: 10.1007/s11095-013-1063-y. View

13.

Zhang W, Shi Y, Chen Y, Hao J, Sha X, Fang X . The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models. Biomaterials. 2011; 32(25):5934-44. DOI: 10.1016/j.biomaterials.2011.04.075. View

14.

Agueros M, Zabaleta V, Espuelas S, Campanero M, Irache J . Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles. J Control Release. 2010; 145(1):2-8. DOI: 10.1016/j.jconrel.2010.03.012. View

15.

Hajrezaie M, Salehen N, Karimian H, Zahedifard M, Shams K, Al Batran R . Biochanin a gastroprotective effects in ethanol-induced gastric mucosal ulceration in rats. PLoS One. 2015; 10(3):e0121529. PMC: 4374864. DOI: 10.1371/journal.pone.0121529. View

16.

Zhang S, Morris M . Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport. J Pharmacol Exp Ther. 2003; 304(3):1258-67. DOI: 10.1124/jpet.102.044412. View

17.

Mitra A, Li L, Marsac P, Marks B, Liu Z, Brown C . Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug. Int J Pharm. 2016; 505(1-2):107-14. DOI: 10.1016/j.ijpharm.2016.03.036. View

18.

Harini R, Ezhumalai M, Pugalendi K . Antihyperglycemic effect of biochanin A, a soy isoflavone, on streptozotocin-diabetic rats. Eur J Pharmacol. 2011; 676(1-3):89-94. DOI: 10.1016/j.ejphar.2011.11.051. View

19.

Peng S, Ritchie D, Cousineau M, Danser E, Dewire R, Floden J . Altered oral bioavailability and pharmacokinetics of P-glycoprotein substrates by coadministration of biochanin A. J Pharm Sci. 2006; 95(9):1984-93. DOI: 10.1002/jps.20664. View

20.

Zhang W, Shi Y, Chen Y, Yu S, Hao J, Luo J . Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance. Eur J Pharm Biopharm. 2010; 75(3):341-53. DOI: 10.1016/j.ejpb.2010.04.017. View